Yeah, but he mentioned it afterwards too... won't bother looking it up since there were so many videos and calls, but unless memory fails me he said something like "we have an interim analysis with 195 patients, but perhaps we can ask FDA to look at it earlier".

Anyway, if they want to make that change, they can ask for it... I agree they should try. 170-180 vs 195 doesn't make too much a difference statistically.